Different papillomaviruses have different repertoires of transcription factor binding sites: Convergence and divergence in the upstream regulatory region

BMC Evolutionary Biology

Volumn 6, Issue , 2006, Pages

  García Vallvé, Santiago ^a   Iglesias Rozas, José R ^b   Alonso, Ángel ^c   Bravo, Ignacio G ^c  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b KATHARINENHOSPITAL   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ARTICLE; BINDING SITE; GENETIC ALGORITHM; NONHUMAN; PAPILLOMA VIRUS; PHYLOGENY; REGULATOR GENE; VIRUS GENOME; CLASSIFICATION; GENETICS; METABOLISM; MOLECULAR EVOLUTION; REGULATORY SEQUENCE; VIRUS GENE;

PAPILLOMAVIRIDAE; PRIMATES; VERTEBRATA;

BINDING SITES; EVOLUTION, MOLECULAR; GENES, VIRAL; GENOME, VIRAL; PAPILLOMAVIRIDAE; PHYLOGENY; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TRANSCRIPTION FACTORS; VIRAL PROTEINS;

EID: 33645532046     PISSN: 14712148     EISSN: 14712148     Source Type: Journal    
DOI: 10.1186/1471-2148-6-20     Document Type: Article

References (36)

1. zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2:342-350.
2. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H: Classification of papillomaviruses. Virology 2004, 324:17-27.
3. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88:63-73.
4. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Meifer CJLM, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
5. Pfister H: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003, 31:52-56.
6. Kaya H, Kotiloglu E, Inanli S, Ekicioglu G, Bozkurt s-U, Tutkum A, Kullu S: Prevalence of human papillomavirus (HPV) DNA in larynx and lung carcinomas. Pathologica 2001, 93:531-534.
7. Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM, Wojnarowska F, Breuer J, McGregor JM: Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 2004, 150:949-957.
8. Longworth MS, Laimins LA: Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 2004, 68:362-372.
9. Apt D, Chong T, Liu Y, Bernard HU: Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J Virol 1993, 67:4455-4463.
10. Bauknecht T, Angel P, Royer HD, zur Hausen H: Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional represor YY1. Embo J 1992, 11:4607-4617.
11. Chong T, Apt D, Gloss B, Isa M, Bernard HU: The enhancer of human papillomavirus type 16: binding sites for the ubiquitious transcriptions factors oct-1, NFA, TEF-2, NF1 and AP-1 participate in epithelial cell-specific transcription. J Virol 1991, 65:5933-5943.
12. Cripe TP, Haugen TH, Turk JP, Tabatabai F, Schmid PG III, Durst M, Gissmann L, Roman A, Turek LP: Transcriptional regulation of the human papillomavirus-166 E6-E7 promoter by a keratinocyte dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. Embo J 1987, 6:3745-3753.
13. Kanaya T, Kyo S, Laimins LA: The 5′ region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1. Virology 1997, 237(1):159-169.
14. O'Connor M, Bernard HU: Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virology 1995, 207:77-88.
15. Offord EA, Beard P: A member of the activator protein 1 family foind in keratinocytes but not in fibroblasts required for transcription from a huma papillomavirus type 18 promoter. J Virol 1990, 64:4792-4798.
16. Steger G, Corbach S: Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral viral E2 protein. J Virol 1997, 71:50-58.
17. Thierry F, Spyrou G, Yaniv M, Howley PM: Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes. J Virol 1992, 66:3740-3748.
18. Villa L, Schlegel R: Differences in transformation activity between HPV-18 and HPV16 map to the viral LCR-E6-E7 region. Virology 1991, 181:374-377.
19. Rose B, Steger G, Dong X, Thompson C, Cossart Y, Tattersall M, Pfister H: Point mutations in SP1 motifs in the upstream regulatory region of human papillomavirus type 18 isolates from cervical cancers increase promoter activity. J Gen Virol 1998, 79:1659-1663.
20. Hubert WG: Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle. J Virol 2005, 79:5914-5922.
21. Garcia-Vallve S, Alonso A, Bravo IG: Papillomaviruses: different genes have different histories. Trends Microbiol 2005, 13:514-521.
22. Bernard HU: The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol 2005, 32S:S1-S6.
23. Spink KM, Laimins LA: Induction of the human papillomavirus type 31 late dependent promoter requires differentiation but not DNA amplification. J Virol 2005, 79:4918-4926.
24. Jackson AP: The effect of paralogous lineages on the application of reconciliation analysis by cophylogeny mapping. Syst Biol 2005, 54:127-145.
25. Chen Z, Terai M, Fu L, Herrero R, DeSalle R, Burk RD: Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol 2005, 79(11):7014-7023.
26. Bravo IG, Alonso A: Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. J Virol 2004, 78:13613-13626.
27. Delsuc F, Brinkmann H, Philippe H: Phylogenomics and the reconstruction of the tree of life. Nat Rev Genet 2005, 6:361-375.
28. Thornton JW, Kolaczkowski B: No magic pill for phylogenetic error. Trends Gen 2005, 21:310-311.
29. O'Connor M, Chan S-Y, Bernard HU: Transcription Factor Binding Sites in the Long Control Region of Genital HPVs. In Human Papillomavirus 1995 Compendium Los Alamos National Laboratory. University of California; 1995.
30. Lassmann T, Sonnhammer ELL: Quality assessment of multiple alignment programs. FEBS Lett 2002, 529:126-130.
31. Malinowski ER: Factor Analysis in Chemistry. New York: Wiley; 1991.
32. Hand DH, Mannila H, Smyth P: Principles of Data Mining. Cambridge, MAS: MIT Press; 2001.
33. Mitchell M: An introduction to genetic algorithms. MIT Press, Cambridge, MA; 1996.
34. Notredame C, Higgins D, Heringa J: T-Coffee: A novel method for multiple sequence alignments. J Mol Biol 2000, 302:205-217.
35. Higgins D, Thompson J, Gibson T, Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive-multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acid Res 1994, 22:4673-4680.
36. Morgenstern B: DIALIGN 2: improvement of the segment-to-segment approach to multiple sequence alignment. Bioinformatics 1999, 15:211-218.